Lonza Group AG | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Lonza Group AG

BRIEF

published on 11/12/2024 at 07:05, 9 days 2 hours ago

Lonza étend ses capacités de bioconjugaison en Suisse

Lonza Durabilité ADC Bioconjugaison Agrandissement De Viège
BRIEF

published on 11/12/2024 at 07:05, 9 days 2 hours ago

Lonza Expands Bioconjugation Capabilities in Switzerland

Sustainability Lonza ADCs Bioconjugation Visp Expansion
PRESS RELEASE

published on 11/12/2024 at 07:00, 9 days 2 hours ago

Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
Lonza announces expansion of bioconjugation capabilities in Visp (CH) with two new manufacturing suites, addressing market demand and offering expertise to a broad customer base

Expansion Manufacturing Lonza Bioconjugation Visp
BRIEF

published on 10/24/2024 at 07:05, 28 days 2 hours ago

Lonza Group AG confirme ses perspectives pour 2024 dans le cadre d'expansions stratégiques

Expansion De La Production Perspectives De Lonza Pour 2024 Acquisition De Genentech Performances Commerciales Des CDMO Accord De Sommet
BRIEF

published on 10/24/2024 at 07:05, 28 days 2 hours ago

Lonza Group AG Confirms 2024 Outlook Amid Strategic Expansions

Manufacturing Expansion Lonza 2024 Outlook Genentech Acquisition CDMO Business Performance Vertex Agreement
PRESS RELEASE

published on 10/24/2024 at 07:00, 28 days 2 hours ago

Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
Lonza confirms Full-Year Outlook 2024 with flat year-on-year sales in CER and high 20s CORE EBITDA margin in Q3 performance update

Sales EBITDA Lonza Full-year Outlook Q3 Performance
BRIEF

published on 10/22/2024 at 07:05, 30 days 2 hours ago

Lonza Extends Partnership for Antibody-Drug Conjugates Supply

Lonza Manufacturing Expansion ADCs Bioconjugation Pharmaceutical Partnership
BRIEF

published on 10/22/2024 at 07:05, 30 days 2 hours ago

Lonza étend son partenariat pour la fourniture de conjugués anticorps-médicaments

Lonza Expansion De La Production ADC Partenariat Pharmaceutique Bioconjugaison
PRESS RELEASE

published on 10/22/2024 at 07:00, 30 days 2 hours ago

Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza extends collaboration with major pharmaceutical partner for integrated commercial supply of antibody-drug conjugates, including construction of dedicated bioconjugation capacity in Visp, and commercial antibody manufacturing for new ADC therapy

Lonza ADCs Commercial Supply Bioconjugation Pharmaceutical Partner
BRIEF

published on 10/03/2024 at 09:05, 1 month 18 days ago

Lonza Nominates David Meline as Independent Board Member

Board Of Directors Annual General Meeting Financial Experience Lonza Group David Meline

1 2 ... 7

Accesswire

Published on 11/21/2024 at 09:00, 42 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 7 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 17 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 42 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 42 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 41 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 42 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 42 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 27 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 32 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 44 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 34 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 22 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE